Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Ortho Clinical Diagnostics Holdings Plc's Business Segments

Ortho Clinical Diagnostics Holdings Plc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q1 FY2022
Reportable Segments
1
Per the company's own filing, this quarter
Largest Segment
Reportable
87.7% of revenue
Total Revenue
$ 500
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/OCDX/segments
https://api.csimarket.com/api/v1/companies/OCDX/geographic
https://api.csimarket.com/api/v1/companies/OCDX/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q1 FY2022

88%largest
  • Reportable87.7%

Revenue by Reportable Segment - Q1 FY2022

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
ReportableQ1 FY2022$ 43987.7%-

Revenue by Product & Service Category - Q1 FY2022

64%largest
  • Clinical Laboratories64.2%
  • Transfusion Medicine34.7%
  • Other Product Revenue0.1%

Revenue by Product & Service Category - Q1 FY2022

CategoryPeriodRevenue
(Millions)
% of Total
Clinical LaboratoriesQ1 FY2022$ 32164.2%
Transfusion MedicineQ1 FY2022$ 17434.7%
Other Product RevenueQ1 FY2022$ 00.1%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

Description of Ortho Clinical Diagnostics Holdings Plc

Ortho Clinical Diagnostics Holdings Plc is a global medical diagnostics company that specializes in developing and manufacturing in vitro diagnostics products and solutions. Founded in 1937, Ortho Clinical Diagnostics has been a leader in the field of clinical diagnostics for over 80 years.

The company operates in more than 100 countries worldwide and serves the clinical laboratory and immunohematology communities with a comprehensive product portfolio. Their products are designed to aid in the diagnosis and management of various diseases and conditions, including infectious diseases, blood transfusions, chronic diseases, and more.

Ortho Clinical Diagnostics offers a wide range of diagnostic systems, reagents, and assays for laboratories of all sizes. Their state-of-the-art platforms enable accurate and reliable testing for a variety of analytes, such as biochemistry, immunoassays, blood typing, and more. The company's products are known for their high quality, precision, and efficiency, helping healthcare providers deliver timely and accurate patient results.

The company has made significant contributions to various medical fields over the years. They were one of the pioneers in blood banking, playing a crucial role in ensuring safe and effective blood transfusions. Additionally, Ortho Clinical Diagnostics has made advancements in infectious disease testing, helping to detect and manage infections like HIV, hepatitis, and Zika virus.

Ortho Clinical Diagnostics is committed to innovation and invests heavily in research and development to bring new diagnostic solutions to the market. They collaborate with healthcare professionals, academic institutions, and industry partners to stay at the forefront of medical technology. This dedication to innovation has led to numerous patents and advancements in diagnostic testing.

In recent years, the company has also focused on developing personalized medicine solutions. These solutions aim to provide tailored treatment options based on an individual's unique genetic makeup and disease characteristics. Ortho Clinical Diagnostics believes that personalized medicine will revolutionize patient care and improve health outcomes.

As a socially responsible company, Ortho Clinical Diagnostics is dedicated to making a positive impact on global health. They prioritize sustainability initiatives, minimize their environmental footprint, and promote responsible business practices. They also support charitable organizations and provide educational resources to improve medical knowledge and patient care worldwide.

In terms of financial performance, Ortho Clinical Diagnostics is a publicly-traded company and operates as a subsidiary of The Carlyle Group, a global investment firm. The company's revenue comes from the sale of diagnostic systems, reagents, and related services. The strong market presence and reputation of Ortho Clinical Diagnostics have contributed to its steady growth and success.

Overall, Ortho Clinical Diagnostics Holdings Plc is a trusted and respected name in the field of clinical diagnostics. Their commitment to innovation, quality, and patient care has made them a leader in the industry, and they continue to strive towards advancing medical diagnostics for the betterment of healthcare worldwide.
Ortho Clinical Diagnostics Holdings Plc specializes in the development, manufacturing, and marketing of innovative in-vitro diagnostics (IVD) solutions used in hospitals, laboratories, and blood banks. The company’s offerings are designed to help healthcare professionals make faster and more accurate medical decisions, optimizing patient care and management.

Segments of Ortho Clinical Diagnostics

1. Clinical Chemistry:
- This segment focuses on the analysis of bodily fluids, primarily blood, to measure various substances, such as enzymes, hormones, and electrolytes. Clinical chemistry tests are crucial for diagnosing conditions such as diabetes, kidney disease, and liver disorders.

2. Transfusion Medicine:
- This segment deals closely with the screening and compatibility testing of blood products for transfusions. It plays a pivotal role in ensuring blood safety and compatibility, minimizing the risk of transfusion reactions. This segment includes products for both blood typing and antibody screening.

3. Immunohematology:
- In this category, Ortho Clinical specializes in blood typing and crossmatching solutions, critical for transfusion medicine. This involves testing to determine blood groups and the presence of antibodies.

4. Molecular Diagnostics:
- This segment encompasses tests that analyze genetic material. These tests can detect pathogens and genetic disorders and are becoming increasingly vital in personalized medicine.

Products and Services

1. Instruments:
- Ortho’s fully automated and semi-automated analyzers cater to varying laboratory needs. These instruments are designed for high throughput, providing reliable results across numerous tests. Examples include systems for clinical chemistry and immunohematology testing.

2. Reagents:
- The company produces a range of reagents used in conjunction with their instruments to conduct various tests. These reagents are formulated for specific assays, including those needed for clinical chemistry and transfusion medicine.

3. Software Solutions:
- Ortho Clinical Diagnostics provides software solutions that assist laboratories in managing data, ensuring compliance, and integrating with existing healthcare systems. This enhances workflow efficiency and data management.

4. Quality Control Products:
- Quality control materials and services are vital in any diagnostic setup. Ortho offers products designed to monitor the performance of laboratory tests, ensuring the accuracy and reliability of results.

5. Support and Training Services:
- The company provides extensive customer support and training services to help laboratory personnel optimize the use of their instruments and reagents. This includes troubleshooting, maintenance, and educational programs.

Applications

- Hospitals and Clinical Laboratories:
- Ortho Clinical Diagnostics’ products are widely used in hospitals and clinical laboratories for routine tests, disease diagnosis, and monitoring health conditions.

- Blood Banks:
- The company’s solutions are integral for blood banks in maintaining safety and compatibility for blood transfusions, ensuring that donated blood products are tested and processed appropriately.

- Research Institutions:
- Their instruments and reagents find applications in research settings, where they contribute to studies related to disease prevention, diagnostics, and treatment.

Innovations

Ortho Clinical Diagnostics actively invests in research and development, constantly striving to improve existing products and create new technologies. Innovations in this space often focus on enhancing assay sensitivity, reducing time-to-result, integrating advanced automation, and harnessing digital technologies for better data analysis and management.

In summary, Ortho Clinical Diagnostics Holdings Plc is a key player in the in-vitro diagnostics industry, offering a diverse array of products and services that span several critical healthcare segments. Their commitment to innovation and quality plays a significant role in shaping diagnostic practices and improving patient outcomes globally.